- Home
- PRPL vs BEAT Comparison
PRPL vs BEAT Comparison
Compare PRPL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- BEAT
- Stock Information
- Founded
- PRPL 2010
- BEAT 2015
- Country
- PRPL United States
- BEAT United States
- Employees
- PRPL N/A
- BEAT N/A
- Industry
- PRPL Home Furnishings
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- PRPL Consumer Discretionary
- BEAT Technology
- Exchange
- PRPL Nasdaq
- BEAT Nasdaq
- Market Cap
- PRPL 90.3M
- BEAT 74.1M
- IPO Year
- PRPL N/A
- BEAT 2021
- Fundamental
- Price
- PRPL $1.01
- BEAT $2.14
- Analyst Decision
- PRPL Buy
- BEAT Buy
- Analyst Count
- PRPL 4
- BEAT 1
- Target Price
- PRPL $2.53
- BEAT $8.00
- AVG Volume (30 Days)
- PRPL 414.7K
- BEAT 117.1K
- Earning Date
- PRPL 03-11-2025
- BEAT 11-07-2024
- Dividend Yield
- PRPL N/A
- BEAT N/A
- EPS Growth
- PRPL N/A
- BEAT N/A
- EPS
- PRPL N/A
- BEAT N/A
- Revenue
- PRPL $504,838,000.00
- BEAT N/A
- Revenue This Year
- PRPL N/A
- BEAT N/A
- Revenue Next Year
- PRPL $1.89
- BEAT N/A
- P/E Ratio
- PRPL N/A
- BEAT N/A
- Revenue Growth
- PRPL N/A
- BEAT N/A
- 52 Week Low
- PRPL $0.75
- BEAT $1.35
- 52 Week High
- PRPL $2.33
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- PRPL 64.41
- BEAT 39.58
- Support Level
- PRPL $0.91
- BEAT $2.08
- Resistance Level
- PRPL $1.03
- BEAT $2.30
- Average True Range (ATR)
- PRPL 0.08
- BEAT 0.15
- MACD
- PRPL 0.02
- BEAT 0.00
- Stochastic Oscillator
- PRPL 92.88
- BEAT 35.00
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.